Table 2.
Results of the in silico pharmacokinetics assessment of the tested compounds.
| Molecule | M.Wt | HBA | HBD | MR | TPSA | GI absorption | BBB | iLogP | Bioavailability | Drug Likeness |
|---|---|---|---|---|---|---|---|---|---|---|
| 9a | 406.52 | 2 | 1 | 124.82 | 107.55 | High | 3.64 | 2.98 | 0.55 | 0.41 |
| 9b | 546.75 | 4 | 1 | 174.78 | 114.03 | High | 3.62 | 4.49 | 0.55 | 1.26 |
| 11c | 406.52 | 2 | 1 | 124.82 | 107.55 | High | 2.99 | 5.62 | 0.55 | 1.03 |
| 11d | 650.86 | 5 | 2 | 206.42 | 134.26 | Low | 2.16 | 5.05 | 0.55 | 1.07 |
| 14 | 378.47 | 2 | 1 | 115.21 | 107.55 | High | 3.74 | 2.64 | 0.55 | 0.22 |
| 16a | 484.57 | 3 | 1 | 144.78 | 107.55 | Low | 3.34 | 4.07 | 0.55 | 0.32 |
| 16b | 472.61 | 2 | 1 | 142.69 | 135.79 | Low | 3.39 | 3.76 | 0.55 | −0.02 |